Modelling [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2020-02-04 12:17 (443 d 23:24 ago) – Posting: # 21143
Views: 2,036

Hi mittyri,

» I don't think the proposed scheme is good enough for modelling such difficult things. There are no Ctau's planned.

Correct, pre-dose values are required. I overlooked that in John’s post.

» Moreover, I would mix the A and B for that purpose.

Stop sampling in SS at 6 (or even 24 hours)? I wouldn’t do that. You might not be able to estimate deeper compartments from SD due to analytical limitations.

» And sorry for a broken link, I cannot carve in my mind that tags for years :-D

No worries.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,429 posts in 4,479 threads, 1,512 registered users;
online 15 (1 registered, 14 guests [including 7 identified bots]).
Forum time: Friday 12:41 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5